Maxim Biomedical Plans to Market Millions of COVID-19 Tests This Year
Several biomedical industries are running to look for tests that will rapidly detect individuals infected with COVID-19. One of these biomedical companies is Maxim Biomedical. The company aims at producing millions of Maxim SARS-COV-2 Rapid Antigen Diagnostic Tests for COVID-19. The test is expected to be ready by the end of the year. How the test operates The test will use the Lateral Flow Assay (“LFA”) technology with a sleek workflow and a closed-tube format to avoid the need for a reader or an expensive tool to perform. Its patent, awaiting approval, contains the reagents, specimen swab, and test strip…